Dupilumab biosimilar approved united states 2026?

I don’t have real-time browsing in this chat, so I can’t confirm the exact status in 2026. As of my last reliable update (mid-2024), there were no FDA-approved dupilumab (Dupixent) biosimilars in the United States. That status could have changed by 2026.

If you want to verify right now, you can check these sources:
- FDA Purple Book: lists approved biosimilars and their license status.
- FDA press releases: announcements of biosimilar approvals.
- Company announcements: investor relations or press releases from potential developers (e.g., companies active in biosimilars).
- FDA drug labeling databases: to confirm current indications and interchangeability status.

If you’d like, I can guide you step-by-step on how to search these sources or help interpret any specific press release you find. If you want me to try to retrieve the latest status, let me know and I’ll outline how to proceed.